Plasma from rheumatoid arthritis patients promotes pro-atherogenic cholesterol transport gene expression in THP-1 human macrophages

Experimental Biology and Medicine

Volumn 238, Issue 10, 2013, Pages 1192-1197

  Voloshyna, Iryna ^a   Modayil, Sony ^a   Littlefield, Michael J ^a   Belilos, Elise ^a   Belostocki, Kristina ^a   Bonetti, Lois ^a   Rosenblum, Gary ^a   Carsons, Steven E ^a   Reiss, Allison B ^a  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

Author keywords

atherosclerosis; cholesterol transport; macrophage; Rheumatoid arthritis

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G1; C REACTIVE PROTEIN; CD36 ANTIGEN; CHOLESTANETRIOL 26 MONOOXYGENASE; CXCL16 CHEMOKINE; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; RHEUMATOID FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL TRANSPORT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; HUMAN CELL; LIPID STORAGE; MACROPHAGE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; ULTRAVIOLET SPECTROPHOTOMETRY; UPREGULATION; WESTERN BLOTTING;

ATHEROSCLEROSIS; CHOLESTEROL TRANSPORT; MACROPHAGE; RHEUMATOID ARTHRITIS;

ADULT; ARTHRITIS, RHEUMATOID; ATHEROSCLEROSIS; BLOTTING, WESTERN; CELL LINE; CHOLESTEROL; FEMALE; GENE EXPRESSION PROFILING; HOMEOSTASIS; HUMANS; MACROPHAGES; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; PLASMA; PROTEOME; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84884638016     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370213503262     Document Type: Article

References (22)

1. Charles-Schoeman C.Cardiovascular disease and rheumatoid arthritis: an update.Curr Rheumatol Rep. 2012;14:455-462.
2. Stamatelopoulos KS,Kitas GD,Papamichael CM,Chryssohoou E,Kyrkou K,Georgiopoulos G,Protogerou A,Panoulas VF,Sandoo A,Tentolouris N,Mavrikakis M,Sfikakis PP.Atherosclerosis in rheumatoid arthritis versus diabetes: a comparative study.Arterioscler Thromb Vasc Biol. 2009;29:1702-1708.
3. Crowson CS,Matteson EL,Roger VL,Therneau TM,Gabriel SE.Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis.Am J Cardiol. 2012;110:420-424.
4. Avina-Zubieta JA,Thomas J,Sadatsafavi M,Lehman AJ,Lacaille D.Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies.Ann Rheum Dis. 2012;71:1524-1529.
5. Sandoo A,Kitas GD,Carroll D,Veldhuijzen van Zanten JJ.The role of inflammation and cardiovascular disease risk on microvascular and macrovascular endothelial function in patients with rheumatoid arthritis: a cross-sectional and longitudinal study.Arthritis Res Ther. 2012;14:R117-R117.
6. McKellar GE,McCarey DW,Sattar N,McInnes IB.Role for TNF in atherosclerosis? Lessons from autoimmune disease.Nat Rev Cardiol. 2009;6:410-417.
7. Libby P.Role of inflammation in atherosclerosis associated with rheumatoid arthritis.Am J Med. 2008;121:S21-31.
8. Reiss AB,Anwar K,Merrill JT,Chan ES,Awadallah NW,Cronstein BN,Michael Belmont H,Belilos E,Rosenblum G,Belostocki K,Bonetti L,Hasneen K,Carsons SE.Plasma from systemic lupus patients compromises cholesterol homeostasis: a potential mechanism linking autoimmunity to atherosclerotic cardiovascular disease.Rheumatol Int. 2010;30:591-598.
9. Reiss AB,Wan DW,Anwar K,Merrill JT,Wirkowski PA,Shah N,Cronstein BN,Chan ES,Carsons SE.Enhanced CD36 scavenger receptor expression in THP-1 human monocytes in the presence of lupus plasma: linking autoimmunity and atherosclerosis.Exp Biol Med (Maywood). 2009;234:354-360.
10. Qin Z.The use of THP-1 cells as a model for mimicking the function and regulation of monocytes and macrophages in the vasculature.Atherosclerosis. 2012;221:2-11.
11. Reiss AB,Glass ADProteins involved in the pathogenesis of atherosclerosis. Reiss ABCarsons SCronstein BN, ed. {black small square}: Research Signpost; 2006:1-12.
12. Pirillo A,Reduzzi A,Ferri N,Kuhn H,Corsini A,Catapano AL.Upregulation of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) by 15-lipoxygenase-modified LDL in endothelial cells.Atherosclerosis. 2011;214:331-337.
13. Lehrke M,Millington SC,Lefterova M,Cumaranatunge RG,Szapary P,Wilensky R,Rader DJ,Lazar MA,Reilly MP.CXCL16 is a marker of inflammation, atherosclerosis, and acute coronary syndromes in humans.J Am Coll Cardiol. 2007;49:442-449.
14. Reiss AB,Awadallah NW,Cronstein BN.Cytochrome P450 cholesterol 27-hydroxylase: an anti-atherogenic enzyme.Recent Res Devel in Lipids Res. 2000;4:39-50.
15. Voloshyna I,Reiss AB.The ABC transporters in lipid flux and atherosclerosis.Prog Lipid Res. 2011;50:213-224.
16. Wang N,Lan D,Chen W,Matsuura F,Tall AR.ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins.Proc Natl Acad Sci USA. 2004;101:9774-9779.
17. Aletaha D,Neogi T,Silman AJ,Funovits J,Felson DT,Bingham CO III,Birnbaum NS,Burmester GR,Bykerk VP,Cohen MD,Combe B,Costenbader KH,Dougados M,Emery P,Ferraccioli G,Hazes JM,Hobbs K,Huizinga TW,Kavanaugh A,Kay J,Kvien TK,Laing T,Mease P,Ménard HA,Moreland LW,Naden RL,Pincus T,Smolen JS,Stanislawska-Biernat E,Symmons D,Tak PP,Upchurch KS,Vencovský J,Wolfe F,Hawker G.2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.Arthritis Rheum. 2010;62:2569-2581.
18. Voloshyna I,Hai O,Littlefield MJ,Carsons SE,Reiss AB.Resveratrol mediates anti-atherogenic effects on cholesterol flux in human macrophages and endothelium via PPAR-γ and adenosine.Eur J Pharmacol. 2013;698:299-309.
19. Popa CD,Arts E,Fransen J,van Riel PL.Atherogenic index and high-density lipoprotein cholesterol as cardiovascular risk determinants in rheumatoid arthritis: the impact of therapy with biologicals.Mediators Inflamm. 2012;2012:785946-785946.
20. Kahlenberg JM,Kaplan MJ.Mechanisms of premature atherosclerosis in rheumatoid arthritis and lupus.Annu Rev Med. 2013;64:249-263.
21. Mirjafari H,Al-Husain A,Bruce IN.Cardiovascular risk factors in inflammatory arthritis.Curr Opin Lipidol. 2011;22:296-301.
22. Reiss AB,Patel CA,Rahman MM,Chan ES,Hasneen K,Montesinos MC,Trachman JD,Cronstein BN.Interferon-gamma impedes reverse cholesterol transport and promotes foam cell transformation in THP-1 human monocytes/macrophages.Med Sci Monit. 2004;10:BR420-425.